drugset / Trial / NCT05866692
A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors
NaSequentialOpen-labelTreatment
Summary
This is a phase I, multicenter, open-label study. The study will investigate the safety, tolerability, PK, and preliminary efficacy of TY-2699a on locally advanced or metastatic solid tumors.
Timeline
- Start
- 2023-08-17
- Primary completion
- 2025-10
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TY-2699a | Unknown | — | Oral |